Lovenox (enoxaparin) is a prescription drug used to prevent or treat certain types of blood clots. Lovenox’s cost may depend on factors such as your dosage, whether you have health insurance, and how ...

The Department of Pharmaceuticals (DoP) has rejected a review application of Sanofi India, part of the leading multinational pharma major Sanofi, and upheld the decision of National Pharmaceutical ...

USA: Aspirin given to patients undergoing hip or knee arthroplasty for osteoarthritis resulted in a significantly higher rate of symptomatic venous thromboembolism (VTE) compared to enoxaparin, says a ...

ELONOX ® and ELONOX ® HP are also backed by KabiCare, a full-service patient support program offering a wide range of services from financial assistance to patient education. "Our company's purpose is ...

Enoxaparin and aspirin as VTE prophylaxis are similarly effective for prevention of mortality among patients undergoing hip or knee arthroplasty. Enoxaparin and aspirin show comparable effectiveness ...

Since its emergence, the COVID-19 pandemic had a dramatic impact on the public health worldwide and it scarred the medical, economical, and social determinants of health. Even after the significant ...

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. It is indicated alone or in combination with ...

It is indicated alone or in combination with warfarin to prevent and treat blood clots in the leg. It is a low molecular weight heparin. Enoxaparin is indicated for preventing and treating blood clots ...

Investigators sought to determine the safety and efficacy of varying doses of enoxaparin regimens in patients receiving a bariatric procedure. The rate of venous thromboembolism (VTE) and major ...

Aspirin alone doesn’t seem to be enough to prevent symptomatic venous thromboembolism (VTE) in the months following total hip or knee replacement for osteoarthritis, results of the CRISTAL trial ...

Reinitiation of oral anticoagulant therapy may be warranted for some patients with atrial fibrillation who have a high risk of bleeding. Researchers sought to determine whether thromboprophylaxis with ...